Edition:
United States

Imerys SA (IMTP.PA)

IMTP.PA on Paris Stock Exchange

62.45EUR
17 Aug 2018
Change (% chg)

€-0.25 (-0.40%)
Prev Close
€62.70
Open
€62.70
Day's High
€62.85
Day's Low
€62.10
Volume
70,213
Avg. Vol
108,606
52-wk High
€87.80
52-wk Low
€61.75

Chart for

About

Imerys SA is a France-based company that is principally engaged in the extraction and processing of minerals. The Company is organized into four Business Groups: Minerals for Ceramics, Refractories, Abrasives and Foundry, which provides a range of products, such as ceramic bodies for porcelain, raw materials for floor tiles and... (more)

Overall

Beta: 0.92
Market Cap(Mil.): €4,951.39
Shares Outstanding(Mil.): 79.60
Dividend: 2.08
Yield (%): 3.31

Financials

  IMTP.PA Industry Sector
P/E (TTM): 19.50 32.15 32.91
EPS (TTM): 3.22 -- --
ROI: 5.62 5.00 7.36
ROE: 11.44 5.76 9.82

Imerys allocates with deep discount on new second lien loan

LONDON, Aug 2 (LPC) - French roofing business Imerys has set final terms on a €580m leveraged loan with a heavy discount on a newly introduced €100m second-lien loan.

Aug 02 2018

Imerys unit settles talc claims for at least $5 million: Bloomberg

A unit of French minerals company Imerys SA settled claims by 22 women related to talc supplied to Johnson & Johnson for making baby powder for at least $5 million, Bloomberg reported on Friday, citing people familiar with the matter.

Jun 01 2018

Imerys unit settles talc claims for at least $5 mln -Bbg

June 1 A unit of French minerals company Imerys SA settled claims by 22 women related to talc supplied to Johnson & Johnson for making baby powder for at least $5 million, Bloomberg reported https://www.bloomberg.com/news/articles/2018-06-01/imerys-unit-said-to-settle-talc-claims-for-at-least-5-million on Friday, citing people familiar with the matter.

Jun 01 2018

U.S. jury fails to reach verdict in latest J&J talc trial

NEW YORK A South Carolina jury on Friday could not agree on a verdict in a case of a woman whose family said her long-term use of Johnson & Johnson's Baby Powder led to her death from asbestos-related cancer, resulting in a mistrial.

May 25 2018

UPDATE 1-U.S. jury fails to reach verdict in latest J&J talc trial

NEW YORK, May 25 A South Carolina jury on Friday could not agree on a verdict in a case of a woman whose family said her long-term use of Johnson & Johnson's Baby Powder led to her death from asbestos-related cancer, resulting in a mistrial.

May 25 2018

U.S. jury fails to reach verdict in latest J&J talc trial over asbestos claims

NEW YORK, May 25 A South Carolina jury on Friday could not agree on a verdict in a case of a woman whose family said her long-term use of Johnson & Johnson's Baby Powder led to her death from asbestos-related cancer, resulting in a mistrial.

May 25 2018

Deals of the day-Mergers and acquisitions

April 18 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:

Apr 18 2018

Exclusive: Imerys selling one billion euro tiles business, buyout funds bidding - sources

LONDON/FRANKFURT France's Imerys is selling its roof tiles business as it streamlines its portfolio, people close to the matter said, expecting the asset to be valued at around 1 billion euros ($1.2 billion), with private equity most likely to clinch the deal.

Apr 18 2018

J&J, Imerys unit must pay $117 million in N.J. asbestos cancer case

NEW YORK Johnson & Johnson and Imerys Talc America, a unit of Imerys SA, must pay $117 million in damages in a case involving a man who said he developed cancer due to his exposure to asbestos in talc-based products, a New Jersey state court jury said on Wednesday.

Apr 11 2018

UPDATE 2-J&J, Imerys unit must pay $117 mln in N.J. asbestos cancer case

NEW YORK, April 11 Johnson & Johnson and Imerys Talc America, a unit of Imerys SA, must pay $117 million in damages in a case involving a man who said he developed cancer due to his exposure to asbestos in talc-based products, a New Jersey state court jury said on Wednesday.

Apr 11 2018

Earnings vs. Estimates